Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when MBOT files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsMicrobot Medical lands first North Carolina customer for LIBERTY robotic system
Filed June 2, 2026 · Period ending June 2, 2026 · ~1 min read
Key Changes
-
medium
Microbot secured its first North Carolina-based healthcare system customer for the LIBERTY Endovascular Robotic System, marking geographic expansion into a new state market.
Item 7.01 verify on EDGAR → -
medium
The new customer demonstrates broadening geographic penetration across the southeast, mid-Atlantic, and northeast U.S. regions for the company's flagship robotic platform.
Press Release verify on EDGAR →
Summary
Microbot Medical announced it has secured its first customer in North Carolina for its LIBERTY Endovascular Robotic System, expanding the company's geographic footprint into a new state market. The healthcare system adoption represents continued commercial traction for Microbot's flagship robotic platform, which is designed for minimally invasive vascular procedures. For retail investors, this announcement signals incremental progress in commercial adoption and geographic diversification beyond the company's existing presence in the southeast, mid-Atlantic, and northeast regions.
While a single customer win is not transformative for a medical device company, it demonstrates ongoing market acceptance and sales execution. Investors should watch for follow-on disclosures about the size of this contract, installation timeline, and whether Microbot can accelerate the pace of new customer additions in 2026. The company's ability to convert geographic expansion into meaningful revenue growth will be the key metric to monitor in upcoming quarterly results.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.
Added in current filing · view on EDGAR → · paraphrased
the Company has secured its first North Carolina-based customer, becoming the latest healthcare system to adopt the LIBERTY® Endovascular Robotic System, demonstrating a broadening geographic penetration from the southeast, mid-Atlantic and northeast U.S.
Microbot Medical announced it has secured its first customer in North Carolina for its LIBERTY Endovascular Robotic System. This represents geographic expansion into a new state market, with the company noting broadening penetration across the southeast, mid-Atlantic, and northeast regions of the United States.
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On June 2, 2026, the Company announced that it has secured its first North Carolina-based customer for the LIBERTY® Endovascular Robotic System, demonstrating a broadening geographic penetration from the southeast, mid-Atlantic and northeast U.S.
Microbot Medical announced securing its first customer in North Carolina for its LIBERTY® Endovascular Robotic System. This represents geographic expansion beyond the company's existing presence in the southeast, mid-Atlantic, and northeast regions of the United States.
Event · Item 9.01 — Financial Statements and Exhibits
Microbot Medical filed an 8-K attaching a press release; no material business event disclosed in the filing body.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Exhibit | Number | Description | 99.1 | Press Release
The 8-K attaches a press release as Exhibit 99.1. The filing body provides no details about the press release content, so the nature and materiality of the disclosed event cannot be determined from this document alone.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 10, 2026 · How we verify